Acute pulmonary effects of aerosolized nicotine

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 316, Issue 1, 2019, Pages L94-L104

  Ahmad, Shama ^a   Zafar, Iram ^a   Mariappan, Nithya ^a   Husain, Maroof ^a   Wei, Chih Chang ^a   Vetal, Nilam ^a   Eltoum, Isam A ^b   Ahmad, Aftab ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Aerosol; Lung injury; Nicotine; Pulmonary edema; Rats

Indexed keywords

CASPASE 3; CASPASE 7; CXCL1 CHEMOKINE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN M; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LACTIC ACID; MESSENGER RNA; MYELOPEROXIDASE; NICOTINE; UVOMORULIN; VASCULOTROPIN; CASP3 PROTEIN, RAT; CASP7 PROTEIN, RAT; CXCL1 PROTEIN, RAT; HBP1 PROTEIN, RAT;

AEROSOL; AIRWAY EPITHELIUM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; BASOPHIL; BRONCHOALVEOLAR LAVAGE FLUID; CELL DEATH; CIGARETTE SMOKING; CONTROLLED STUDY; ENZYME ACTIVITY; EOSINOPHIL COUNT; EXPERIMENTAL LUNG INJURY; IN VITRO STUDY; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; LUNG ALVEOLUS EPITHELIUM CELL; LUNG EDEMA; LUNG WET TO DRY WEIGHT RATIO; MALE; MRNA EXPRESSION LEVEL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PARTICLE SIZE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION LEVEL; PROTEIN SECRETION; RAT; RESPIRATORY TRACT PARAMETERS; TRANSEPITHELIAL RESISTANCE; ADVERSE EVENT; ANIMAL; BLOOD; DRUG EFFECT; INJURY; LUNG GAS EXCHANGE; METABOLISM; NEUTROPHIL; PATHOLOGY; SPRAGUE DAWLEY RAT; VAPING;

AEROSOLS; ANIMALS; BLOOD-AIR BARRIER; CASPASE 3; CASPASE 7; CHEMOKINE CXCL1; HMGB1 PROTEIN; IMMUNOGLOBULIN M; INTERLEUKIN-1ALPHA; LEUKOCYTE COUNT; MALE; NEUTROPHIL INFILTRATION; NEUTROPHILS; NICOTINE; PARTICLE SIZE; PULMONARY EDEMA; RATS; RATS, SPRAGUE-DAWLEY; VAPING;

EID: 85059860485     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00564.2017     Document Type: Article

References (81)

1. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol 165: 2950–2954, 2000. doi:10.4049/jimmunol.165.6.2950.
2. Adriani W, Macrì S, Pacifici R, Laviola G. Peculiar vulnerability to nicotine oral self-administration in mice during early adolescence. Neu-ropsychopharmacology 27: 212–224, 2002. doi:10.1016/S0893-133X(02) 00295-6.
3. Ahmad A, Ahmad S, Glover L, Miller SM, Shannon JM, Guo X, Franklin WA, Bridges JP, Schaack JB, Colgan SP, White CW. Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells. Proc Natl Acad Sci USA 106: 10684–10689, 2009. doi:10.1073/pnas.0901326106.
4. 2 -ATPase expression in cystic fibrosis airways: role in oxidant-mediated cell death. Am J Respir Crit Care Med 179: 816–826, 2009. doi:10.1164/rccm. 200807-1104OC.
5. Ahmad S, Nichols DP, Strand M, Rancourt RC, Randell SH, White CW, Ahmad A. SERCA2 regulates non-CF and CF airway epithelial cell response to ozone. PLoS One 6: e27451, 2011. doi:10.1371/journal.pone. 0027451.
6. Andrus PG, Rhem R, Rosenfeld J, Dolovich MB. Nicotine microaerosol inhaler. Can Respir J 6: 509–512, 1999. doi:10.1155/1999/530496.
7. Behar RZ, Hua M, Talbot P. Puffing topography and nicotine intake of electronic cigarette users. PLoS One 10: e0117222, 2015. doi:10.1371/journal.pone.0117222.
8. Behera D, Dash S, Sen S. Neutrophil count and myeloperoxidase activity in Indian bidi smokers. Respiration 61: 269–273, 1994. doi:10.1159/000196350.
9. Bennett WD, Brown JS, Zeman KL, Hu SC, Scheuch G, Sommerer K. Targeting delivery of aerosols to different lung regions. J Aerosol Med 15: 179–188, 2002. doi:10.1089/089426802320282301.
10. Biskos GV, Yurteri CU, Schmidt-Ott A. Generation and sizing of particle for aerosol-based nanotechnology. Kona Powder Particle J 26: 13–35, 2008. doi:10.14356/kona.26.2008006.
11. Bodine BG, Bennion BG, Leatham E, Jimenez FR, Wright AJ, Jer-gensen ZR, Erickson CJ, Jones CM, Johnson JP, Knapp SM, Reynolds PR. Conditionally induced RAGE expression by proximal airway epithelial cells in transgenic mice causes lung inflammation. Respir Res 15: 133, 2014. doi:10.1186/s12931-014-0133-y.
12. Burns AR, Hosford SP, Dunn LA, Walker DC, Hogg JC. Respiratory epithelial permeability after cigarette smoke exposure in guinea pigs. J Appl Physiol (1985) 66: 2109–2116, 1989. doi:10.1152/jappl.1989.66.5. 2109.
13. Calfee CS, Matthay MA, Eisner MD, Benowitz N, Call M, Pittet JF, Cohen MJ. Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med 183: 1660–1665, 2011. doi:10.1164/rccm.201011-1802OC.
14. Chandna AR, Nair M, Chang C, Pennington PR, Yamamoto Y, Mousseau DD, Campanucci VA. RAGE mediates the inactivation of nAChRs in sympathetic neurons under high glucose conditions. Eur J Neurosci 41: 341–351, 2015. doi:10.1111/ejn.12795.
15. Chatham-Stephens K, Law R, Taylor E, Melstrom P, Bunnell R, Wang B, Apelberg B, Schier JG; Centers for Disease Control and Prevention (CDC). Notes from the field: calls to poison centers for exposures to electronic cigarettes–United States, September 2010-Febru-ary 2014. MMWR Morb Mortal Wkly Rep 63: 292–293, 2014.
16. Chen BC, Bright SB, Trivedi AR, Valento M. Death following intentional ingestion of e-liquid. Clin Toxicol (Phila) 53: 914–916, 2015. doi:10.3109/15563650.2015.1090579.
17. Chen YC, Statt S, Wu R, Chang HT, Liao JW, Wang CN, Shyu WC, Lee CC. High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells. Sci Rep 6: 18815, 2016. doi:10.1038/srep18815.
18. Corkery JM, Button J, Vento AE, Schifano F. Two UK suicides using nicotine extracted from tobacco employing instructions available on the Internet. Forensic Sci Int 199: e9–e13, 2010. doi:10.1016/j.forsciint.2010. 02.004.
19. Crowley-Weber CL, Dvorakova K, Crowley C, Bernstein H, Bernstein C, Garewal H, Payne CM. Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem Biol Interact 145: 53–66, 2003. doi:10.1016/S0009-2797(02)00162-X.
20. England LJ, Bunnell RE, Pechacek TF, Tong VT, McAfee TA. Nicotine and the developing human: a neglected element in the electronic cigarette debate. Am J Prev Med 49: 286–293, 2015. doi:10.1016/j. amepre.2015.01.015.
21. Erlandsson Harris H, Andersson U. Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol 34: 1503–1512, 2004. doi:10.1002/eji.200424916.
22. Etter JF, Bugey A. E-cigarette liquids: constancy of content across batches and accuracy of labeling. Addict Behav 73: 137–143, 2017. doi:10.1016/j.addbeh.2017.05.012.
23. Farsalinos K. Electronic cigarettes: an aid in smoking cessation, or a new health hazard? Ther Adv Respir Dis 12: 1753465817744960, 2018. doi: 10.1177/1753465817744960.
24. Garcia-Arcos I, Geraghty P, Baumlin N, Campos M, Dabo AJ, Jundi B, Cummins N, Eden E, Grosche A, Salathe M, Foronjy R. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax 71: 1119–1129, 2016. doi:10.1136/thoraxjnl-2015-208039.
25. Govindarajan P, Spiller HA, Casavant MJ, Chounthirath T, Smith GA. E-cigarette and liquid nicotine exposures among young children. Pediatrics 141: e20173361, 2018. doi:10.1542/peds.2017-3361.
26. Gowadia N, Oldham MJ, Dunn-Rankin D. Particle size distribution of nicotine in mainstream smoke from 2R4F, Marlboro Medium, and Quest1 cigarettes under different puffing regimens. Inhal Toxicol 21: 435–446, 2009. doi:10.1080/08958370802512535.
27. Guzik K, Skret J, Smagur J, Bzowska M, Gajkowska B, Scott DA, Potempa JS. Cigarette smoke-exposed neutrophils die unconventionally but are rapidly phagocytosed by macrophages. Cell Death Dis 2: e131, 2011. doi:10.1038/cddis.2011.13.
28. Hage AN, Krause W, Mathues A, Krasner L, Kasten S, Eliason JL, Ghosh A. Comparing the effects of electronic cigarette vapor and cigarette smoke in a novel in vivo exposure system. J Vis Exp 123: e55672, 2017. doi:10.3791/55672.
29. Hamza RZ, El-Shenawy NS. Anti-inflammatory and antioxidant role of resveratrol on nicotine-induced lung changes in male rats. Toxicol Rep 4: 399–407, 2017. doi:10.1016/j.toxrep.2017.07.003.
30. Hansen LK, Grimm RH Jr, Neaton JD. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol 19: 881– 888, 1990. doi:10.1093/ije/19.4.881.
31. Hansson L, Choudry NB, Karlsson JA, Fuller RW. Inhaled nicotine in humans: effect on the respiratory and cardiovascular systems. J Appl Physiol (1985) 76: 2420–2427, 1994. doi:10.1152/jappl.1994.76.6.2420.
32. Haswell LE, Papadopoulou E, Newland N, Shepperd CJ, Lowe FJ. A cross-sectional analysis of candidate biomarkers of biological effect in smokers, never-smokers and ex-smokers. Biomarkers 19: 356–367, 2014. doi:10.3109/1354750X.2014.912354.
33. Haussmann HJ, Fariss MW. Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se. Crit Rev Toxicol 46: 701–734, 2016. doi:10.1080/10408444. 2016.1182116.
34. Higham A, Rattray NJ, Dewhurst JA, Trivedi DK, Fowler SJ, Gooda-cre R, Singh D. Electronic cigarette exposure triggers neutrophil inflammatory responses. Respir Res 17: 56, 2016. doi:10.1186/s12931-016-0368-x.
35. Hong W, Peng G, Hao B, Liao B, Zhao Z, Zhou Y, Peng F, Ye X, Huang L, Zheng M, Pu J, Liang C, Yi E, Peng H, Li B, Ran P. Nicotine-induced airway smooth muscle cell proliferation involves TRPC6-dependent calcium influx via 7 nAChR. Cell Physiol Biochem 43: 986–1002, 2017. doi:10.1159/000481651.
36. Iribarren C, Jacobs DR Jr, Sidney S, Gross MD, Eisner MD. Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting. Chest 117: 163–168, 2000. doi:10.1378/chest. 117.1.163.
37. Iskandar AR, Gonzalez-Suarez I, Majeed S, Marescotti D, Sewer A, Xiang Y, Leroy P, Guedj E, Mathis C, Schaller JP, Vanscheeuwijck P, Frentzel S, Martin F, Ivanov NV, Peitsch MC, Hoeng J. A framework for in vitro systems toxicology assessment of e-liquids. Toxicol Mech Methods 26: 389–413, 2016. doi:10.3109/15376516.2016.1170251.
38. Jerry JM, Collins GB, Streem D. E-cigarettes: safe to recommend to patients? Cleve Clin J Med 82: 521–526, 2015. doi:10.3949/ccjm.82a. 14054.
39. Kleinstreuer C, Feng Y. Lung deposition analyses of inhaled toxic aerosols in conventional and less harmful cigarette smoke: a review. Int J Environ Res Public Health 10: 4454–4485, 2013. doi:10.3390/ijerph10094454.
40. Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, Schroeder DR, Jiang NS. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J Clin Pharmacol 38: 502–509, 1998. doi:10.1002/j.1552-4604.1998.tb05787.x.
41. Lee HW, Park SH, Weng MW, Wang HT, Huang WC, Lepor H, Wu XR, Chen LC, Tang MS. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci USA 115: E1560–E1569, 2018. doi:10.1073/pnas.1718185115.
42. Lerner CA, Sundar IK, Yao H, Gerloff J, Ossip DJ, McIntosh S, Robinson R, Rahman I. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 10: e0116732, 2015. doi:10.1371/journal.pone.0116732.
43. Lindsay RP, Tsoh JY, Sung HY, Max W. Secondhand smoke exposure and serum cotinine levels among current smokers in the USA. Tob Control 25: 224–231, 2016. doi:10.1136/tobaccocontrol-2014-051782.
44. Lu Q, Gottlieb E, Rounds S. Effects of cigarette smoke on pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 314: L743–L756, 2018. doi:10.1152/ajplung.00373.2017.
45. Marsot A, Simon N. Nicotine and cotinine levels with electronic cigarette: a review. Int J Toxicol 35: 179–185, 2016. doi:10.1177/1091581815618935.
46. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stoler-man IP, Tyndale RF, Wehner JM, Zirger JM. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190: 269–319, 2007. doi:10.1007/s00213-006-0441-0.
47. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM; Acute Lung Injury in Animals Study Group. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 44: 725–738, 2011. doi:10.1165/rcmb.2009-0210ST.
48. Mohammad G, Siddiquei MM, Othman A, Al-Shabrawey M, Abu El-Asrar AM. High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. Exp Eye Res 107: 101–109, 2013. doi:10.1016/j.exer.2012. 12.009.
49. Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, Wollum A, Sanman E, Wulf S, Lopez AD, Murray CJ, Gakidou E. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA 311: 183–192, 2014. doi:10.1001/jama.2013. 284692.
50. Ni YF, Tian F, Lu ZF, Yang GD, Fu HY, Wang J, Yan XL, Zhao YC, Wang YJ, Jiang T. Protective effect of nicotine on lipopolysaccharide-induced acute lung injury in mice. Respiration 81: 39–46, 2011. doi:10. 1159/000319151.
51. Oldham MJ, Zhang J, Rusyniak MJ, Kane DB, Gardner WP. Particle size distribution of selected electronic nicotine delivery system products. Food Chem Toxicol 113: 236–240, 2018. doi:10.1016/j.fct.2018.01.045.
52. Padon AA, Lochbuehler K, Maloney EK, Cappella JN. A Randomized Trial of the Effect of Youth Appealing E-Cigarette Advertising on Susceptibility to Use E-Cigarettes Among Youth. Nicotine Tob Res 20: 954–961, 2018. doi:10.1093/ntr/ntx155.
53. Paulson JR, Yang T, Selvaraj PK, Mdzinarishvili A, Van der Schyf CJ, Klein J, Bickel U, Abbruscato TJ. Nicotine exacerbates brain edema during in vitro and in vivo focal ischemic conditions. J Pharmacol Exp Ther 332: 371–379, 2010. doi:10.1124/jpet.109.157776.
54. Phillips B, Esposito M, Verbeeck J, Boué S, Iskandar A, Vuillaume G, Leroy P, Krishnan S, Kogel U, Utan A, Schlage WK, Bera M, Veljkovic E, Hoeng J, Peitsch MC, Vanscheeuwijck P. Toxicity of aerosols of nicotine and pyruvic acid (separate and combined) in Sprague-Dawley rats in a 28-day OECD 412 inhalation study and assessment of systems toxicology. Inhal Toxicol 27: 405–431, 2015. doi:10.3109/08958378.2015.1046000.
55. Ponzoni L, Moretti M, Sala M, Fasoli F, Mucchietto V, Lucini V, Cannazza G, Gallesi G, Castellana CN, Clementi F, Zoli M, Gotti C, Braida D. Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice. Eur Neuropsychopharmacol 25: 1775–1786, 2015. doi:10.1016/j.euroneuro.2015.06.010.
56. Pouwels SD, Heijink IH, ten Hacken NH, Vandenabeele P, Krysko DV, Nawijn MC, van Oosterhout AJ. DAMPs activating innate and adaptive immune responses in COPD. Mucosal Immunol 7: 215–226, 2014. doi:10.1038/mi.2013.77.
57. Pratte P, Cosandey S, Goujon-Ginglinger C. A scattering methodology for droplet sizing of e-cigarette aerosols. Inhal Toxicol 28: 537–545, 2016. doi:10.1080/08958378.2016.1224956.
58. Riddle SR, Ahmad A, Ahmad S, Deeb SS, Malkki M, Schneider BK, Allen CB, White CW. Hypoxia induces hexokinase II gene expression in human lung cell line A549. Am J Physiol Lung Cell Mol Physiol 278: L407–L416, 2000. doi:10.1152/ajplung.2000.278.2.L407.
59. Robinson AB, Stogsdill JA, Lewis JB, Wood TT, Reynolds PR. RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease. Front Physiol 3: 301, 2012. doi:10.3389/fphys.2012.00301.
60. Rowell TR, Tarran R. Will chronic e-cigarette use cause lung disease? Am J Physiol Lung Cell Mol Physiol 309: L1398–L1409, 2015. doi:10. 1152/ajplung.00272.2015.
61. Sajja RK, Rahman S, Cucullo L. Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress. J Cereb Blood Flow Metab 36: 539–554, 2015. doi:10.1177/0271678X15616978.
62. Saxena K, Liang Q, Muhammad-Kah R, Sarkar M. Evaluating the relationship between biomarkers of potential harm and biomarkers of tobacco exposure among current, past, and nonsmokers: data from the National Health and Nutrition Examination Survey 2007–2012. Biomarkers 22: 1–10, 2016. doi:10.1080/1354750X.2016.1201536.
63. Schweitzer KS, Chen SX, Law S, Van Demark M, Poirier C, Justice MJ, Hubbard WC, Kim ES, Lai X, Wang M, Kranz WD, Carroll CJ, Ray BD, Bittman R, Goodpaster J, Petrache I. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol 309: L175–L187, 2015. doi:10.1152/ajplung.00411.2014.
64. Shao XM, López-Valdés HE, Liang J, Feldman JL. Inhaled nicotine equivalent to cigarette smoking disrupts systemic and uterine hemody-namics and induces cardiac arrhythmia in pregnant rats. Sci Rep 7: 16974, 2017. doi:10.1038/s41598-017-17301-5.
65. Shao XM, Xu B, Liang J, Xie XS, Zhu Y, Feldman JL. Nicotine delivery to rats via lung alveolar region-targeted aerosol technology produces blood pharmacokinetics resembling human smoking. Nicotine Tob Res 15: 1248–1258, 2013. doi:10.1093/ntr/nts261.
66. Smith KR, Uyeminami DL, Kodavanti UP, Crapo JD, Chang LY, Pinkerton KE. Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant. Free Radic Biol Med 33: 1106–1114, 2002. doi:10.1016/S0891-5849(02)01003-1.
67. Sommerfeld K, Łukasik-Głębocka M, Kulza M, Drużdż A, Panieński P, Florek E, Zielińska-Psuja B. Intravenous and oral suicidal e-liquid poisonings with confirmed nicotine and cotinine concentrations. Forensic Sci Int 262: e15–e20, 2016. doi:10.1016/j.forsciint.2016.03.005.
68. Terashima T, Klut ME, English D, Hards J, Hogg JC, van Eeden SF. Cigarette smoking causes sequestration of polymorphonuclear leukocytes released from the bone marrow in lung microvessels. Am J Respir Cell Mol Biol 20: 171–177, 1999. doi:10.1165/ajrcmb.20.1.3276.
69. Thomas RJ, Webber D, Sellors W, Collinge A, Frost A, Stagg AJ, Bailey SC, Jayasekera PN, Taylor RR, Eley S, Titball RW. Characterization and deposition of respirable large-and small-particle bioaerosols. Appl Environ Microbiol 74: 6437–6443, 2008. doi:10. 1128/AEM.01194-08.
70. Tsoyi K, Jang HJ, Kim JW, Chang HK, Lee YS, Pae HO, Kim HJ, Seo HG, Lee JH, Chung HT, Chang KC. Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine attenuates inflammatory response in macrophages and improves survival in experimental model of sepsis through heme oxygenase-1 induction. Antioxid Redox Signal 14: 2057– 2070, 2011. doi:10.1089/ars.2010.3555.
71. Vakkalanka JP, Hardison LS Jr, Holstege CP. Epidemiological trends in electronic cigarette exposures reported to U.S. Poison Centers. Clin Toxicol (Phila) 52: 542–548, 2014. doi:10.3109/15563650.2014.913176.
72. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res 15: 267–270, 2013. doi:10.1093/ntr/ntr316.
73. Waldum HL, Nilsen OG, Nilsen T, Rørvik H, Syversen V, Sanvik AK, Haugen OA, Torp SH, Brenna E. Long-term effects of inhaled nicotine. Life Sci 58: 1339–1346, 1996. doi:10.1016/0024-3205(96)00100-2.
74. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216–1221, 2004. doi:10.1038/nm1124.
75. Ware LB, Lee JW, Wickersham N, Nguyen J, Matthay MA, Calfee CS, California Transplant Donor N; California Transplant Donor Network. Donor smoking is associated with pulmonary edema, inflammation and epithelial dysfunction in ex vivo human donor lungs. Am J Transplant 14: 2295–2302, 2014. doi:10.1111/ajt.12853.
76. Weiss D, Tomasallo CD, Meiman JG, Creswell PD, Melstrom PC, Gummin DD, Patel DJ, Michaud NT, Sebero HA, Anderson HA. Electronic cigarette exposure: calls to wisconsin poison control centers, 2010–2015. WMJ 115: 306–310, 2016.
77. Williams RS, Derrick J, Liebman AK, LaFleur K. Content analysis of e-cigarette products, promotions, prices and claims on Internet tobacco vendor websites, 2013–2014. Tob Control 27: e34–e40, 2018. doi:10. 1136/tobaccocontrol-2017-053762.
78. Wu Q, Jiang D, Minor M, Chu HW. Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One 9: e108342, 2014. doi:10.1371/journal.pone. 0108342.
79. Xu Y, Li H, Bajrami B, Kwak H, Cao S, Liu P, Zhou J, Zhou Y, Zhu H, Ye K, Luo HR. Cigarette smoke (CS) and nicotine delay neutrophil spontaneous death via suppressing production of diphosphoinositol pen-takisphosphate. Proc Natl Acad Sci USA 110: 7726–7731, 2013. doi:10. 1073/pnas.1302906110.
80. Yokohira M, Nakano Y, Hashimoto N, Yamakawa K, Ninomiya F, Kishi S, Saoo K, Imaida K. Toxicity of nicotine by repeated intratracheal instillation to f344 rats. J Toxicol Pathol 25: 257–263, 2012. doi:10.1293/tox.25.257.
81. Zaky A, Bradley WE, Lazrak A, Zafar I, Doran S, Ahmad A, White CW, Dell’Italia LJ, Matalon S, Ahmad S. Chlorine inhalation-induced myocardial depression and failure. Physiol Rep 3: 3, 2015. doi:10.14814/phy2.12439.